VENCLAXTA 10 mg Tablet contains Venetoclax 10 mg. It is an anticancer medicine that belongs to the class of BCL-2 inhibitors. It works by blocking the BCL-2 protein, which helps cancer cells survive, leading to the death of abnormal blood cancer cells.
Uses:
Treatment of certain blood cancers, including:
Chronic lymphocytic leukemia (CLL)
Small lymphocytic lymphoma (SLL)
Acute myeloid leukemia (AML) in combination with other medicines (as prescribed by a specialist)
Helps reduce the growth and survival of abnormal cancer cells.
Dose:
Dose depends on the type of cancer, treatment combination, and patient's response; prescribed by an oncologist.
Usually started with a gradual dose increase (ramp-up schedule) to reduce the risk of tumor lysis syndrome.
Take the tablet exactly as directed by the physician.
Swallow the tablet whole with water; do not crush, chew, or break unless advised.
Take with food as instructed by the doctor.
Regular monitoring of blood counts, kidney function, and other laboratory tests is required.
Do not stop or change the dose without medical advice.